RESEARCH · RESEARCH · #1749
Lancet study: Google’s AMIE chatbot aided clinicians and matched diagnoses in 98‑patient pilot
Researchers from Google and Beth Israel Deaconess Medical Center published a real‑world study in The Lancet reporting that 98 patients used AMIE, a diagnostic AI chatbot, before urgent‑care visits at a BIDMC ambulatory clinic. Supervising physicians monitored interactions (no conversation triggered predefined safety interruptions); clinicians said AMIE summaries helped prepare for visits in 75% of cases, influenced care in >50%, and AMIE’s differential diagnoses matched doctors’ final diagnoses 90% of the time, though authors note larger trials are needed.
KEY POINTS
- Researchers from Google and Beth Israel Deaconess Medical Center published a real‑world study in The Lancet reporting that 98 patients used AMIE, a diagnostic AI chatbot, before urgent‑care visits at a BIDMC ambulatory clinic.
- Supervising physicians monitored interactions (no conversation triggered predefined safety interruptions); clinicians said AMIE summaries helped prepare for visits in 75% of cases, influenced care in >50%, and AMIE’s differential diagnoses matched doctors’ final diagnoses 90% of the time, though authors note larger trials are needed.
- The study provides preliminary clinical evidence that a patient‑facing diagnostic AI (AMIE) can safely assist pre‑visit assessment and meaningfully aid clinician preparation and differential diagnosis, though results are from a small pilot and require larger trials.
WHY IT MATTERS
The study provides preliminary clinical evidence that a patient‑facing diagnostic AI (AMIE) can safely assist pre‑visit assessment and meaningfully aid clinician preparation and differential diagnosis, though results are from a small pilot and require larger trials.